Prevacent® PRRS
Prevacent® PRRS
Effective for the vaccination of healthy pigs 2 weeks of age or older against porcine reproductive and respiratory syndrome (PRRS); and against reproductive disease when vaccinated 6 weeks prior to breeding.
Bottle Size
20 dose; 100 dose; 250 dose
PRRS Control from the Start
- Safe.
- Smooth.
- Effective.
PRRS Control from the Start
1 mL dose that is safe for all gestational stages3
Reduced lung lesions4,5
Contemporary & homologous
Pig Trial Summary
In a commercial study, Prevacent PRRS-vaccinated pigs showed no reduction in growth performance or difference in body weight at day 50 or day 125.6
Prevacent did not shed through the air during the 28-day sampling period.
In pigs, Prevacent caused less viremia than an MLV competitor on days 14 to 35 post-vaccination.7
CT Value of Unvaccinated Controls at Time of Removal from Housing with Vaccinated Pigs7
Sow Trial Summary
Viremia: Total Positive8
Piglet Birth Weight8
Viremia Results for all Gilts8
Ad hoc statistical analysis of viremia results performed post-study completion. Treatment by day interaction: P < 0.0001; treatment effect: P = 0.0168 for all gilts.
Whole Herd PRRS Control
- PRRS increases mortality and reduces growth performance of wean-to-finish pigs. PRRS may also cause an increase in the number of premature farrowings, late term abortions, stillborn piglets and mummified fetuses.9
- With no reduction in growth performance or an impact on farrowing as a result of vaccination, Prevacent is a safe and effective solution for PRRS control across production segments.3,8
Get Full Value from start to finish
Our portfolio offers solutions that manage disease challenges and mitigate mortality to optimize health.
Respiratory Health
Managing both enteric and respiratory health challenges are critical to your herd's success.
The label contains complete use information, including cautions and warnings. Always read, follow and understand the label and use directions.
INDICATIONS:
- This product has been shown to be effective for the vaccination of healthy pigs 2 weeks of age or older against PRRS respiratory disease; and against reproductive disease when vaccinated 6 weeks prior to breeding.
- The duration of immunity against respiratory disease is at least 26 weeks.
- The duration of immunity against reproductive disease has not been established. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.
- Safety of this product has been demonstrated when sows or gilts are vaccinated prior to breeding or at any stage of pregnancy.
- Vaccine virus may be shed and transmitted to other populations of swine in contact with vaccinated swine.
- The duration of potential vaccine virus transmission may vary.
- Use of the vaccine in herds intended to remain PRRS virus seronegative is contraindicated.
- Introduction of vaccinated pigs into herds intended to remain PRRS virus seronegative is contraindicated.
DOSAGE AND ADMINISTRATION:
- Rehydrate with the accompanying sterile diluent.
- Shake well and draw back into the syringe the required amount.
- Administer 1 mL intramuscularly.
- The need for annual booster vaccinations has not been established for this product; consultation with a veterinarian is recommended.
IMPORTANT SAFETY INFORMATION
PRECAUTIONS:
- Store at 2°- 8°C (35°- 46°F). DO NOT FREEZE.
- Use entire contents when first opened.
- Do not mix with other products, except as specified on this label. In case of human exposure, contact a physician.
- Do not vaccinate within 21 days before slaughter.
- Inactivate unused contents before disposal.
- Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine. Contains gentamicin as preservative.
